GlassScriptPhysician profile
Kenneth Nwogu
NPI 1891340808
$4,400.49
in general payments reported to CMS, 2019-2025
12 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $323 · 2023: $741 · 2024: $1,674 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,937 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,937.43 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,117.08 | 2021-2025 | Caplyta |
| Indivior INC. | $670.10 | 2022-2025 | Sublocade |
| Abbvie INC. | $620.98 | 2023-2025 | |
| Braeburn INC. | $604.46 | 2023-2025 | Brixadi |
| Supernus Pharmaceuticals, INC. | $519.65 | 2024-2025 | Qelbree |
| Alkermes, INC. | $294.52 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $280.23 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Vanda Pharmaceuticals INC. | $127.87 | 2024-2025 | Fanapt |
| Axsome Therapeutics, INC. | $62.32 | 2025 | Auvelity |
| Tempus Ai, INC | $55.31 | 2024 | |
| Exact Sciences Corporation | $28.55 | 2025 | Cologuard Collection Kit |
| Orexo US, INC. | $19.42 | 2024 | Zubsolv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Nwogu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.